Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: DrugBank:EXPT01586 (
G418
)
2,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The INK4a gene, one of the most often disrupted loci in human cancer, encodes two unrelated proteins, p16(INK4a) and p14(
ARF
) (
ARF
) both capable of inducing cell cycle arrest. Although it has been clearly demonstrated that
ARF
inhibits cell cycle via p53 stabilization, very little is known about the involvement of
ARF
in other cell cycle regulatory pathways, as well as on the mechanisms responsible for activating
ARF
following oncoproliferative stimuli. In search of factors that might associate with
ARF
to control its activity or its specificity, we performed a yeast two-hybrid screen. We report here that the human homologue of spinophilin/neurabin II, a regulatory subunit of protein phosphatase 1 catalytic subunit specifically interacts with
ARF
, both in yeast and in mammalian cells. We also show that ectopic expression of spinophilin/neurabin II inhibits the formation of
G418
-resistant colonies when transfected into human and mouse cell lines, regardless of p53 and
ARF
status. Moreover, spinophilin/
ARF
coexpression in Saos-2 cells, where
ARF
ectopic expression is ineffective, somehow results in a synergic effect. These data demonstrate a role for spinophilin in cell growth and suggest that
ARF
and spinophilin could act in partially overlapping pathways.
...
PMID:The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein. 1127 17
INK4a/
ARF
locus distinguishes itself by its unusual structure and function. It contains 2 overlapping genes with exons 1 alpha, 2 and 3 encoding p16INK4a and exons 1 beta, 2 and 3 encoding p19ARF. Mice with their exons 2 and 3 of the INK4a/
ARF
knocked out are viable and fertile but develop spontaneous tumors at an early age and highly sensitive to carcinogenic treatment. However, mice with their exon 1 beta knocked out, without interference the expression of p16INK4a, show almost the same phenotype as those with their exons 2 and 3 knocked out. This raises a question of whether the mouse p16INK4a plays a role in tumor suppression. To investigate this problem, a targeting vector pointing to p16INK4a exon 1 alpha with 1.5 kb Eco81 I/Acc II fragment as short arm and 5.9 kb Xba I/Xho I fragment as long arm was built. After linearlization and purification, the targeting vector was introduced into ES cells through electroporation. Thirty-seven
G418
- and gancyclovir-resistant colonies were picked out and one of them was confirmed as positive by Southern hybridization.
...
PMID:[p16INK4a exon 1 alpha knockout in mouse embryonic stem cells]. 1183 70